Heung Tae Kim

5.3k total citations · 2 hit papers
137 papers, 4.1k citations indexed

About

Heung Tae Kim is a scholar working on Pulmonary and Respiratory Medicine, Plant Science and Oncology. According to data from OpenAlex, Heung Tae Kim has authored 137 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pulmonary and Respiratory Medicine, 52 papers in Plant Science and 51 papers in Oncology. Recurrent topics in Heung Tae Kim's work include Lung Cancer Treatments and Mutations (42 papers), Plant Pathogens and Fungal Diseases (40 papers) and Lung Cancer Research Studies (26 papers). Heung Tae Kim is often cited by papers focused on Lung Cancer Treatments and Mutations (42 papers), Plant Pathogens and Fungal Diseases (40 papers) and Lung Cancer Research Studies (26 papers). Heung Tae Kim collaborates with scholars based in South Korea, United States and Japan. Heung Tae Kim's co-authors include Ji‐Youn Han, Tak Yun, Jin Soo Lee, Jin Soo Lee, Hyae Young Kim, Sung Jin Yoon, Dae Ho Lee, Jong Hee Han, Myung‐Ju Ahn and Keunchil Park and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Heung Tae Kim

127 papers receiving 4.0k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung

2012 611 citations Ji‐Youn Han, Dae Ho Lee et al. Journal of Clinical Oncology profile →
Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus

2018 362 citations Manish A. Shah, Takashi Kojima et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heung Tae Kim South Korea	30	2.2k	2.1k	1.1k	623	553	137	4.1k
Jung‐Shin Lee South Korea	31	1.3k 0.6×	1.4k 0.7×	2.4k 2.2×	310 0.5×	376 0.7×	110	4.8k
Mark S. Roh United States	28	906 0.4×	2.1k 1.0×	757 0.7×	1.6k 2.5×	214 0.4×	172	4.3k
Makoto Tahara Japan	43	3.1k 1.4×	4.1k 2.0×	1.5k 1.4×	2.2k 3.6×	653 1.2×	379	9.0k
Juan Carlos Roa Chile	39	1.7k 0.8×	2.0k 1.0×	2.1k 1.9×	2.9k 4.6×	1.1k 2.1×	247	5.7k
Qi Liu China	28	598 0.3×	1.1k 0.5×	976 0.9×	767 1.2×	397 0.7×	168	3.2k
Tokujiro Yano Japan	35	1.8k 0.8×	1.4k 0.7×	804 0.7×	423 0.7×	357 0.6×	143	3.3k
Teh‐Ying Chou Taiwan	34	1.2k 0.6×	1.1k 0.5×	1.5k 1.3×	315 0.5×	641 1.2×	93	3.6k
Clara Natoli Italy	34	575 0.3×	1.7k 0.8×	2.0k 1.8×	318 0.5×	509 0.9×	151	4.8k
Annalisa Astolfi Italy	39	1.6k 0.8×	1.1k 0.5×	1.7k 1.5×	612 1.0×	680 1.2×	178	4.6k
Carla Vindigni Italy	34	1.4k 0.6×	749 0.4×	766 0.7×	1.7k 2.8×	412 0.7×	110	3.9k

Countries citing papers authored by Heung Tae Kim

Since Specialization

Citations

This map shows the geographic impact of Heung Tae Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heung Tae Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heung Tae Kim more than expected).

Fields of papers citing papers by Heung Tae Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heung Tae Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heung Tae Kim. The network helps show where Heung Tae Kim may publish in the future.

Co-authorship network of co-authors of Heung Tae Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Heung Tae Kim. A scholar is included among the top collaborators of Heung Tae Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heung Tae Kim. Heung Tae Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Sungyoung, Sungyoung Lee, Heung Tae Kim, et al.. (2025). Model‐Informed Optimal Dosing of Anti‐CD47 Antibody Using Target‐Mediated Drug Disposition Model. Clinical and Translational Science. 18(8). e70321–e70321.

Choi, Seong‐Ho, et al.. (2024). Elucidation of the Mechanism of Resistance Development of Colletotrichum horii Causing Persimmon Anthracnose to Tebuconazole. Research in Plant Disease. 30(4). 362–371. 1 indexed citations

Park, Subin & Heung Tae Kim. (2023). Evaluation of Acitivity of QoI Fungicide against Colletotrichum acutatum s. lat. Causing Pepper Anthracnose Using Resazurin-Based Respiration Assay. Research in Plant Disease. 29(1). 11–22. 2 indexed citations

Choi, Wonyoung, Seog-Yun Park, Ji‐Youn Han, et al.. (2020). Ceritinib-Induced Organizing Pneumonia in Lung Cancer: A Retrospective Analysis. Targeted Oncology. 15(4). 513–522. 2 indexed citations

Park, Subin, et al.. (2019). Control Effects of Several Fungicides on Jujube Anthracnose and Fungicide Resistance Monitoring. SHILAP Revista de lepidopterología. 25(4). 188–195. 3 indexed citations

Shah, Manish A., Takashi Kojima, Peter C. Enzinger, et al.. (2018). Pembrolizumab for patients with previously treated metastatic adenocarcinoma or squamous cell carcinoma of the esophagus: Phase 2 KEYNOTE-180 study.. Journal of Clinical Oncology. 36(15_suppl). 4049–4049. 7 indexed citations

Lee, Youngjoo, Youngjoo Lee, Geon Kook Lee, et al.. (2014). Clinical outcome according to the level of preexisting epidermal growth factor receptor T790M mutation in patients with lung cancer harboring sensitive epidermal growth factor receptor mutations. Cancer. 120(14). 2090–2098. 52 indexed citations

Lee, Young Joo, Kyong‐Ah Yoon, Ji‐Youn Han, et al.. (2011). Circulating Cell-Free DNA in Plasma of Never Smokers with Advanced Lung Adenocarcinoma Receiving Gefitinib or Standard Chemotherapy as First-Line Therapy. Clinical Cancer Research. 17(15). 5179–5187. 64 indexed citations

Cho, Jungho, et al.. (2011). Study on Adsorption Kinetic Characteristics of Propineb Pesticide on Activated Carbon. Clean Technology. 17(4). 346–352. 1 indexed citations

10.

Kim, Heung Tae, et al.. (2008). Akt1 inhibition by RNA interference sensitizes human non‐small cell lung cancer cells to cisplatin. International Journal of Cancer. 122(10). 2380–2384. 41 indexed citations

11.

Han, Ji‐Youn, Hyeong‐Seok Lim, Eun‐Soon Shin, et al.. (2007). Influence of the organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphisms on irinotecan-pharmacokinetics and clinical outcome of patients with advanced non-small cell lung cancer. Lung Cancer. 59(1). 69–75. 69 indexed citations

12.

Han, Ji‐Youn, Hyeong‐Seok Lim, Eun‐Soon Shin, et al.. (2007). Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan‐pharmacokinetics and clinical outcome in patients with advanced non‐small cell lung cancer. Cancer. 110(1). 138–147. 157 indexed citations

13.

Han, Ji‐Youn, Dae Ho Lee, Sungyoung Lee, et al.. (2005). Phase II study of weekly irinotecan plus capecitabine for chemotherapy‐naive patients with advanced nonsmall cell lung carcinoma. Cancer. 104(12). 2759–2765. 14 indexed citations

14.

Choi, Gyung Ja, et al.. (2005). Antifungal activity against plant pathogenic fungi of chaetoviridins isolated fromChaetomium globosum. FEMS Microbiology Letters. 252(2). 309–313. 132 indexed citations

15.

Kim, Heung Tae, Young Ryun Chung, & Kwang Yun Cho. (2001). Mycelial Melanization of Rhizoctonia solani AG1 Affecting Pathogenicity in Rice. Plant Pathology Journal. 17(4). 210–215. 13 indexed citations

16.

Choi, Gyung Ja, et al.. (2001). Activity against plant pathogenic fungi of phomalactone isolated from Nigrospora sphaerica. Pest Management Science. 57(6). 554–559. 97 indexed citations

17.

Im, Young‐Hyuck, Heung Tae Kim, Isaac Yi Kim, et al.. (2001). Heterozygous mice for the transforming growth factor-beta type II receptor gene have increased susceptibility to hepatocellular carcinogenesis.. PubMed. 61(18). 6665–8. 44 indexed citations

18.

Cho, Kwang Yun, et al.. (1998). Fungicidal Effects of Herbicides on Several Plant Diseases and Controlling Effect of Piperophos on Rice Blast caused by Pyricularia grisea. Plant Pathology Journal. 14(1). 28–33. 1 indexed citations

19.

Kim, Heung Tae & Isamu Yamaguchi. (1996). Effect of Pencycuron on Fluidity of Lipid Membranes of <i>Rhizoctonia solani</i>. Journal of Pesticide Science. 21(3). 323–328. 3 indexed citations

20.

Chung, Young Ryun, Byung Sup Kim, Heung Tae Kim, & Kwang Yun Cho. (1990). Identification of Exserohilum species, a Fungal Pathogen Causing Leaf Blight of Barnyardgrass (Echinochloa crus-galli). Plant Pathology Journal. 6(4). 429–433. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact